LNTH
Price:
$103.86
Market Cap:
$6.76B
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium generator essential for nuclear medicine; Xenon-133, used to assess pulmonary function; Neurolite, which helps identify stroke-damaged areas in the brain;...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-25
Stock Exchange
NASDAQ
Ticker
LNTH
According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 24.79. This represents a change of 24.38% compared to the average of 19.93 of the last 4 quarters.
The mean historical PE Ratio of Lantheus Holdings, Inc. over the last ten years is 15.15. The current 24.79 PE Ratio has changed 16.26% with respect to the historical average. Over the past ten years (40 quarters), LNTH's PE Ratio was at its highest in in the September 2019 quarter at 52.22. The PE Ratio was at its lowest in in the March 2023 quarter at -498.55.
Average
15.15
Median
13.85
Minimum
-53.96
Maximum
124.29
Discovering the peaks and valleys of Lantheus Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.97%
Maximum Annual PE Ratio = 124.29
Minimum Annual Increase = -556.04%
Minimum Annual PE Ratio = -53.96
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 19.23 | -2.82% |
| 2024 | 19.79 | 52.91% |
| 2023 | 12.94 | -89.59% |
| 2022 | 124.29 | -556.04% |
| 2021 | -27.25 | -49.49% |
| 2020 | -53.96 | -313.10% |
| 2019 | 25.32 | 71.50% |
| 2018 | 14.76 | 138.97% |
| 2017 | 6.18 | -39.65% |
| 2016 | 10.24 | -281.74% |
The current PE Ratio of Lantheus Holdings, Inc. (LNTH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
17.32
5-year avg
29.80
10-year avg
15.15
Lantheus Holdings, Inc.’s PE Ratio is greater than Indivior Pharmaceuticals Inc (19.05), greater than ACADIA Pharmaceuticals Inc. (9.70), less than Amneal Pharmaceuticals, Inc. (42.78), greater than ADMA Biologics, Inc. (12.04), greater than Supernus Pharmaceuticals, Inc. (-86.78), greater than Praxis Precision Medicines, Inc. (-21.08), greater than HUTCHMED (China) Limited (3.86), greater than Hinge Health, Inc. (-10.54), greater than Bausch Health Companies Inc. (-1.49), greater than Crinetics Pharmaceuticals, Inc. (-6.98),
| Company | PE Ratio | Market cap |
|---|---|---|
| 19.05 | $4.78B | |
| 9.70 | $3.70B | |
| 42.78 | $5.17B | |
| 12.04 | $1.93B | |
| -86.78 | $2.58B | |
| -21.08 | $5.97B | |
| 3.86 | $1.79B | |
| -10.54 | $5.37B | |
| -1.49 | $1.78B | |
| -6.98 | $3.78B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lantheus Holdings, Inc.'s PE Ratio?
How is the PE Ratio calculated for Lantheus Holdings, Inc. (LNTH)?
What is the highest PE Ratio for Lantheus Holdings, Inc. (LNTH)?
What is the 3-year average PE Ratio for Lantheus Holdings, Inc. (LNTH)?
What is the 5-year average PE Ratio for Lantheus Holdings, Inc. (LNTH)?
How does the current PE Ratio for Lantheus Holdings, Inc. (LNTH) compare to its historical average?